Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 36Lymphoma, Large B-Cell, Diffuse 16Lymphoma 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Burkitt Lymphoma 7Neoplasms 6Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Lymphoma, Follicular 6Leukemia 6Lymphoma, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Recurrence 3Neoplasm Metastasis 3Lymphoma, T-Cell 3Lymphoma, B-Cell, Marginal Zone 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Pain 2Neoplasms by Histologic Type 2Myelodysplastic Syndromes 2Lymphatic Diseases 2Immunoproliferative Disorders 2Immune System Diseases 2Hematologic Neoplasms 2Hematologic Diseases 2Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumours 1Sezary Syndrome 1

Interventions

fludarabine phosphate 6Rituximab 5Antilymphocyte Serum 5Tacrolimus 4Cyclophosphamide 4pegaspargase 3Whole-Body Irradiation 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Oxaliplatin 3Mycophenolic Acid 3Etoposide 3Dasatinib 3Vincristine 2Melphalan 2Lenalidomide 2Gemcitabine 2Filgrastim 2Doxorubicin 2Busulfan 2tislelizumab 1thymoglobulin 1tanespimycin 1plerixafor 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1obatoclax 1gemcitabine-oxaliplatin regimen 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma, Extranodal NK-T-Cell × Prednisone × Clear all
NCT02359162 2018-05-09

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Sun Yat-sen University

Phase 3 Terminated
50 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡